In clinical use, significant side effects are uncommon, and the vast majority of patients tolerate the therapy without problems
We work with major insurers like UnitedHealthcare, Cigna, Blue Cross Blue Shield, Aetna, as well as Medicare Part D and Medicaid, contingent on state-specific availability
Contact your prescriber to discuss dose adjustment, timing modifications under medical supervision, or alternative formulations like oral semaglutide
I feel my best I felt in years since starting my hormone replacement therapy
Always check current rules of racing commissions and FEI guidelines
is a member of the scientific advisory board of ERX Pharmaceuticals, was a member of the Research Cluster Advisory Panel (ReCAP) of the Novo Nordisk Foundation between 2017 and 2019, attended a scientific advisory board meeting of the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, in 2016, received funding for research projects from Novo Nordisk (20162020) and Sanofi-Aventis (20122019), and was a consultant for Bionorica SE (20132017), Menarini Ricerche S.p.A